Bayer’s takeover of Monsanto approved by US Justice Department after $9 billion spin-off agreement

webimage C D A EE D CA CF CD DF B
Image credit: MGN Image

Federal antitrust regulators have granted agribusiness giants Bayer and Monsanto permission to merge after the two companies agreed to spin off $9 billion worth of assets, the largest such sale of corporate assets ever required by the Department of Justice.

Under the proposed settlement filed Tuesday [May 29], Bayer will sell its seed and herbicide businesses to a third party, the German chemical company BASF. It also will sell its emerging digital farming business as well as a range of intellectual property and R&D projects.

The targeted spinoffs are aimed at preventing Bayer and Monsanto from using their combined control over seeds and seed treatments to raise the price of agricultural products to farmers and consumers, Justice Department officials said. Just six companies, including Bayer and Monsanto, have historically dominated the global trade in seeds and agrochemicals.

The deal already has received approval from regulators in the European Union, Russia and Brazil, making the U.S. approval one of the last major hurdles.

Read full, original post: Justice Department approves Bayer-Monsanto merger in landmark settlement

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-May-7-2026-12_16_37-PM-2
Viewpoint: Are cancer rates ‘skyrocketing’ as RFK, Jr. and MAHA claims? The evidence says mostly the opposite
Screenshot-2026-04-13-at-1.39.26-PM
Viewpoint: ‘Safer for children?’ Stonyfield yogurt under fire for deceptive organic marketing
Screenshot-2026-04-22-at-10.46.29-AM
Viewpoint: How to counter science disinformation? Science journalist offers 12 practical tips
png-pill-omega-Supp-fish-oil
Millions take omega-3 fish oil for brain health. New research suggests it may do the opposite.
ChatGPT Image May 14, 2026, 09_51_35 PM
Facebook swamped by hundreds of thousands of scam ads for illegal or dangerous medical products
ChatGPT Image May 12, 2026, 01_21_30 PM
How big health brands are funding online medical misinformation 
Screenshot-2026-04-23-at-11.00.36-AM
Regulators' dilemma: Thalidomide, Metformin, and the cost of getting drug approvals wrong
Picture1-5
Science Disinformation Gap: The transatlantic battle over social media and censorship
ChatGPT-Image-May-13-2026-12_43_37-PM-2
Longevity: Is cellular rejuvenation even possible?
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.